The expression of Imatinib efflux (ABCB1, ABCG2) and influx (SLC22A1) transporters in CD34+ as well as bulk CML cells was compared. The gene discussed is SLC22A1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.